Transconjunctival Sutureless 25-Gauge Vitrectomy

Transconjunctival Sutureless 25-Gauge Vitrectomy for Visually Significant Vitreous Floaters in Patients With Multifocal Intraocular Lens

Status

Completed

Phases

Phase 3

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00870597

Acronym

TSV-25G

Enrollment

Registered

2009-03-27

Start date

2007-01-31

Completion date

2008-12-31

Last updated

2009-03-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Visual Acuity

Keywords

Floaters, multifocal IOL, visual complaints, vitrectomy

Brief summary

The aim of this study was to evaluate the role of 25-gauge transconjuntival sutureless vitrectomy (TSV) in patients with persistent vitreous floaters who underwent multifocal intraocular lens (IOL) implantation.

Detailed description

Purpose: The aim of this study was to evaluate the role of 25-gauge transconjuntival sutureless vitrectomy (TSV) in patients with persistent vitreous floaters who underwent multifocal intraocular lens (IOL) implantation. Setting: Hospital Oftalmológico de Brasília, Brasília, DF, Brazil. Methods: Fourteen eyes of 11 patients with multifocal IOL implant associated with vitreous opacities that underwent 25-gauge vitrectomy were prospectively analyzed. Information collected included near and distance uncorrected visual acuity (UCDVA), best corrected distance visual acuity (BCDVA), and the spherical equivalent (SE) before and 3 months after vitrectomy. Patients were questioned about surgery satisfaction and visual improvement after vitrectomy.

Interventions

PROCEDUREMultifocal IOL implantation + Vitrectomy

25-gauge transconjuntival sutureless vitrectomy (TSV)

PROCEDUREMultifocal IOL implantation - Vitrectomy

Multifocal IOL implantation without transconjunctival vitrectomy

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender

ALL

Age

21 Years to No maximum

Healthy volunteers

Inclusion criteria

* disabling vitreous floaters * Age-related cataract Unsatisfactory correction with glasses

Exclusion criteria

* central endothelial cell count less than 2000 cells/mm2 * glaucoma or intraocular pressure greater than 21 mmHg * amblyopia * retinal abnormalities * diabetes mellitus * steroid or immunosuppressive treatment * connective tissue diseases

Design outcomes

Primary

Measure	Time frame
The aim of this study was to evaluate the role of 25-gauge transconjuntival sutureless vitrectomy (TSV) in patients with persistent vitreous floaters who underwent multifocal intraocular lens (IOL) implantation	1 year

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026